Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
RA
.
Show all posts
Showing posts with label
RA
.
Show all posts
Monday, November 24, 2014
New drug combination shows promise as effective, safe treatment for rheumatoid arthritis
›
A new drug combination for rheumatoid arthritis treats the disease just as well as other intensive treatment strategies but with less medi...
4 comments:
Monday, July 23, 2012
RA Study Misses Primary Endpoint (CH-4051)...
›
In continuation of my update on CH-4051 Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced that a preliminary analysis of...
Friday, June 1, 2012
FDA AAC recommends approval of Pfizer’s tofacitinib for RA
›
In continuation of my update on Tofacitinib ... FDA AAC recommends approval of Pfizer’s tofacitinib for RA : Pfizer Inc. the Arthriti...
Wednesday, May 23, 2012
Pfizer seeks FDA support for its new anti-rheumatoid arthritis pill
›
In continuation of my update on Tofacitinib Pfizer seeks FDA support for its new anti-rheumatoid arthritis pill : Pfizer is waiting...
Sunday, June 19, 2011
FDA approves Watson's Nabumetone Tablets for treatment of osteoarthritis, RA
›
FDA approves Watson's Nabumetone Tablets for treatment of osteoarthritis, RA
Tuesday, May 31, 2011
UCB,s new data for Cimzia® (certolizumab pegol) showed a rapid clinical response across a broad population of RA patients
›
UCB, announced data which showed that the addition of Cimzia ® ( certolizumab pegol ) to current therapy was associated with a rapid and ...
›
Home
View web version